TIDMEMIS
RNS Number : 3772M
EMIS Group PLC
21 January 2021
21 January 2021
EMIS Group plc
("EMIS Group" or "the Group")
Trading update
Notice of final results
EMIS Group plc (AIM: EMIS.L), the UK leader in connected
healthcare software and systems, today announces a trading update
for the year ended 31 December 2020.
Overview
Following an improvement in the second half, trading for the
year was marginally ahead of the Board's expectations, with both
revenue and adjusted operating profit maintained at similar levels
to the previous year.
Divisional review
In EMIS Health, the Group remains a key partner to the NHS and
its leading market shares were maintained, with increased Covid-19
related sales of lower margin hardware adding to the division's
steady underlying growth.
In EMIS Enterprise , trading improved gradually over the second
half of the year as expected, including in the Analytics business,
with the controlled release of EMIS-X Analytics in the final
quarter of the year.
The Group has continued to support the NHS in its fight against
Covid-19 in a variety of areas, including the deployment of its
Pinnacle solution to support the government's vaccination
programme. The Group is working with the NHS to scale up the
software beyond the previous system capacity to meet the
unprecedented demands of the rapidly expanding vaccination
programme while maintaining high performance standards.
Having successfully transitioned its teams to homeworking in
March 2020, the Group has adopted a policy of being primarily a
homeworking organisation, which has continued to serve the Group's
customers and staff well during successive lockdown periods.
Therefore while the continued restrictions increase uncertainty,
the Group does not anticipate a significant impact on its ability
to trade normally through the latest national lockdown.
As previously indicated, the Group has continued to invest in
the development of its next generation technology throughout the
period.
Financial position
The Group has a strong balance sheet with net cash of GBP53.0m
as at 31 December 2020 (31 December 2019: GBP31.1m), including
GBP7.3m of deferred VAT payments which will be paid in the next
quarter.
Notice of final results
The Group intends to announce its final results for the year
ended 31 December 2020 on Thursday 18 March 2021. There will be a
webcast presentation for analysts and institutional investors on
the day, which will also be available on the Group's website;
please contact emis@mhpc.com for further information.
Andy Thorburn, Chief Executive Officer of EMIS Group, said:
"In these extraordinary times I am proud that EMIS has risen to
the challenge of supporting our national heroes in the NHS, in
community pharmacy and across the healthcare sector. Our
mission-critical digital, analytics, clinical, dispensing and
partner systems have been deployed to enable and support our NHS
customers' impressive response to this pandemic.
"Most importantly, our people at EMIS have been tirelessly
supporting our customers and our colleagues throughout 2020 and
continue to do so with the Pinnacle and EMIS Web system work now
being undertaken to support the government's national vaccination
programme. The level of commitment from our team has been
extraordinary.
"I am pleased that our trading improved in the second half of
the year and believe this reflects the strength of our business
model and of our team. The Board remains confident in the outlook
for the business."
For further information, contact:
EMIS Group plc Tel: 0113 380 3000
Andy Thorburn, CEO
Peter Southby, CFO
www.emisgroupplc.com
Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000
Oliver Hardy/Simon Willis/James Black
MHP Communications Tel: 020 3128 8168
Reg Hoare/Giles Robinson/Florence Mayo/Pandora Yadgaroff emis@mhpc.com
Information for investors, including analyst consensus
forecasts, can be found on the Group's website at
www.emisgroupplc.com/investors .
Notes to Editors
EMIS Group is the UK leader in connected healthcare software and
systems. Its solutions are widely used across every major UK
healthcare setting. EMIS Group's aim is to join up healthcare
through innovative technology, helping to deliver better health
outcomes to the UK population, supporting longer and healthier
lives.
EMIS Group has two core business segments: EMIS Health and EMIS
Enterprise.
EMIS Health is a supplier of innovative integrated care
technology to the NHS, including primary, community, acute and
social care.
EMIS Enterprise is focussed on growth in the
business-to-business technology sector within the healthcare
market, including management of medicines, partner businesses and
patient-facing services.
LEI: 213800K474ZZK76NX913
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTPPUCPGUPGGMU
(END) Dow Jones Newswires
January 21, 2021 02:00 ET (07:00 GMT)
Emis (LSE:EMIS)
Historical Stock Chart
From Apr 2024 to May 2024
Emis (LSE:EMIS)
Historical Stock Chart
From May 2023 to May 2024